$24.30
-0.26-1.06%
Last update: Dec 16, 10:37 AM
Comments
Loading...
Apellis Pharmaceuticals Stock Guidance | NASDAQ:APLS | Benzinga
Apellis Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
FAQ
What is the most recent guidance for Apellis Pharmaceuticals (APLS)?
There have been no specific sales or earnings guidance reported for Apellis Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.
